US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
US7332648B2
(en)
|
1995-08-31 |
2008-02-19 |
Roslin Institute |
Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
|
GB9517779D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
EP0941310A1
(de)
|
1996-10-11 |
1999-09-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Verfahren zur erzeugung primordialer keimzellen und transgene tierarten
|
AU8154398A
(en)
*
|
1997-01-10 |
1999-01-25 |
University Of Massachusetts |
Cloning using donor nuclei from non-serum starved, differentiated cells
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
CA2289277C
(en)
|
1997-04-24 |
2013-02-12 |
University Of Washington |
Targeted gene modification by parvoviral vectors
|
EP0989995A2
(de)
|
1997-06-19 |
2000-04-05 |
The General Hospital Corporation |
Torsin, dafür kodierende gene, und deren verwendungen
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
WO1999005266A2
(en)
*
|
1997-07-26 |
1999-02-04 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
CA2300972A1
(en)
*
|
1997-08-22 |
1999-03-04 |
Biotechnology And Biological Sciences Research Council |
Use of mariner transposan in the production of transgenic animals
|
AU1581899A
(en)
*
|
1997-10-28 |
1999-05-17 |
Biotransplant Incorporated |
Nuclear transfer for production of transgenic animal embryo
|
ATE278775T1
(de)
*
|
1998-01-16 |
2004-10-15 |
Agrobiogen Gmbh |
Effizienter kerntransfer mit fetalen fibroblasten
|
US6331659B1
(en)
*
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
EP1067834A4
(de)
*
|
1998-03-16 |
2002-01-23 |
Garelag Pty Ltd |
Kerntransfer bei schweinen
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
AU6218899A
(en)
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
EP1375654A3
(de)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Transgen- und klonierte Saugentiere
|
CA2350233A1
(en)
*
|
1998-11-02 |
2000-05-11 |
Genzyme Transgenics Corp. |
Transgenic and cloned mammals
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
DE69940700D1
(de)
|
1998-11-19 |
2009-05-20 |
Pharming Intellectual Pty Bv |
Stabilisierung der milch transgener tieren
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
JP2002534118A
(ja)
*
|
1999-01-13 |
2002-10-15 |
ピーピーエル セラピューティクス (スコットランド) リミテッド |
二重核移植法及びその結果物
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
AU3382800A
(en)
|
1999-02-26 |
2000-09-14 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
NZ514620A
(en)
*
|
1999-03-04 |
2004-04-30 |
Ppl Therapeutics Scotland Ltd |
Genetic modification of somatic cells and uses thereof
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
CA2370385A1
(en)
*
|
1999-04-28 |
2000-11-02 |
Universite De Montreal |
Telophase enucleated oocytes for nuclear transfer
|
WO2000074477A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Istituto Zootecnico E Caseario Per La Sardegna |
Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby
|
WO2001000855A1
(en)
|
1999-06-23 |
2001-01-04 |
Ppl Therapeutics (Scotland) Ltd. |
Fusion proteins incorporating lysozyme
|
WO2001000650A1
(en)
|
1999-06-30 |
2001-01-04 |
Advanced Cell Technology, Inc. |
Cytoplasmic transfer to de-differentiate recipient cells
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
CA2334954A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Woo-Suk Hwang |
A method for producing cloned tigers by employing inter-species nuclear transplantation technique
|
WO2001000793A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Hwang, Woo-Suk |
Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
|
CN1304443A
(zh)
|
1999-06-30 |
2001-07-18 |
黄禹锡 |
一种生产克隆牛的方法
|
CA2383456C
(en)
|
1999-08-23 |
2016-06-07 |
Clive Wood |
Pd-1, a receptor for b7-4, and uses therefor
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
EP2275559A3
(de)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimierte Boten-RNA (mRNA)
|
CA2385015A1
(en)
*
|
1999-09-30 |
2001-04-05 |
Genzyme Transgenics Corporation |
Methods of producing cloned and transgenic mammals
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
WO2001068831A2
(en)
|
2000-03-15 |
2001-09-20 |
The University Of Georgia Research Foundation, Inc. |
Effective nuclear reprogramming in mammals
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
WO2001088096A2
(en)
*
|
2000-05-15 |
2001-11-22 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
CA2413857C
(en)
|
2000-06-28 |
2010-04-27 |
Genetics Institute, Llc. |
Pd-l2 molecules: pd-1 ligands and uses therefor
|
WO2002009510A2
(en)
*
|
2000-08-01 |
2002-02-07 |
Xy Genetics, Llc |
Methods of selecting and cloning animals
|
CA2634294A1
(en)
|
2000-08-03 |
2002-02-14 |
Therapeutic Human Polyclonals, Inc. |
Production of humanized antibodies in transgenic animals
|
WO2002014473A2
(en)
|
2000-08-15 |
2002-02-21 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
WO2002019811A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
BR0115715A
(pt)
|
2000-11-28 |
2004-02-03 |
Wyeth Corp |
Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
|
AU3650302A
(en)
|
2000-11-28 |
2002-06-11 |
Wyeth Corp |
Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
ATE466089T1
(de)
|
2000-12-22 |
2010-05-15 |
Agronomique Inst Nat Rech |
Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
DE60144248D1
(de)
*
|
2000-12-22 |
2011-04-28 |
Kyowa Hakko Kirin Co Ltd |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
EP1860199B1
(de)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulierte Signalisierung von Insulinrezeptoren
|
MXPA03006751A
(es)
|
2001-01-30 |
2005-04-08 |
Amy K Rebholtz |
Metodos para el manejo de recipientes para embriones.
|
WO2002062131A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Infigen, Inc. |
Method of cloning transgenic mammalian animals using pseudonuclei
|
MXPA03007492A
(es)
*
|
2001-02-20 |
2004-10-15 |
Rheogene Holdings Inc |
Receptores de retinoide x quimerico y su uso en un sistema de expresion de gen inducible basado en receptor de ecdisona novedoso.
|
CA2438832A1
(en)
|
2001-02-23 |
2002-09-06 |
Elan Pharmaceuticals, Inc. |
Transgenic knockouts of bace-1
|
JP2002262716A
(ja)
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
WO2002072762A2
(en)
*
|
2001-03-08 |
2002-09-19 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
AU2002242854A1
(en)
*
|
2001-03-21 |
2002-10-03 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
CA2442066C
(en)
|
2001-04-02 |
2005-11-01 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
WO2002078449A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Advanced Cell Technology, Inc. |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
EP2258842A1
(de)
|
2001-04-16 |
2010-12-08 |
Wyeth Holdings Corporation |
Polypeptidantigene codierende offene Leseraster aus Streptococcus Pneumoniae und Verwendungen davon
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
WO2002092791A1
(en)
*
|
2001-05-14 |
2002-11-21 |
Stell |
Tissues or organs for use in xenotransplantation
|
WO2003005810A2
(en)
*
|
2001-07-09 |
2003-01-23 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
CA2921821A1
(en)
|
2001-07-12 |
2003-01-23 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
AU2002326483A1
(en)
*
|
2001-07-31 |
2003-02-17 |
Simon Eric Aspland |
Genetically modified cows having reduced susceptibility to mad cow disease
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
US7091006B2
(en)
|
2001-11-09 |
2006-08-15 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, a novel PGC-1 homologue and uses therefor
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
WO2003087341A2
(en)
|
2002-01-23 |
2003-10-23 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
ATE531796T1
(de)
*
|
2002-03-21 |
2011-11-15 |
Sangamo Biosciences Inc |
Verfahren und zusammensetzungen zur verwendung von zinkfinger-endonukleasen zur verbesserung der homologen rekombination
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
CN1650003A
(zh)
*
|
2002-04-01 |
2005-08-03 |
Gtc生物治疗学公司 |
选择用于哺乳动物种中核转移的细胞系的方法
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
US7410797B2
(en)
*
|
2002-06-11 |
2008-08-12 |
Ogle Roy C |
Meningeal-derived stem cells
|
US7612250B2
(en)
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
ATE519862T1
(de)
|
2002-08-20 |
2011-08-15 |
Millennium Pharm Inc |
Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs
|
EP2806025B1
(de)
|
2002-09-05 |
2019-04-03 |
California Institute of Technology |
Verwendung von Zinkfingernukleasen zur Stimulierung von Gentargeting
|
US7122361B2
(en)
|
2002-10-10 |
2006-10-17 |
Wyeth |
Compositions employing a novel human kinase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
US7208306B2
(en)
|
2002-10-24 |
2007-04-24 |
Wyeth |
Compositions employing a novel human protein phosphatase
|
JP2006505291A
(ja)
|
2002-11-08 |
2006-02-16 |
ヘマテック,エルエルシー |
プリオンタンパク質活性が低減されたトランスジェニック有蹄動物及びその用途
|
CA2505416A1
(en)
|
2002-11-21 |
2004-06-10 |
Wyeth |
Methods for diagnosing rcc and other solid tumors
|
WO2004050831A2
(en)
|
2002-11-27 |
2004-06-17 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
EP1578192A4
(de)
*
|
2002-12-10 |
2006-03-29 |
Gtc Biotherapeutics Inc |
Verfahren und system zur verwendung vongeklonten kerntransferembryonen als zellspender für einen zusätzlichenkerntransfer
|
EP2474631B1
(de)
|
2002-12-20 |
2014-02-12 |
Celera Corporation |
Mit Myokardinfarkt assoziierte genetische Polymorphismen, Nachweisverfahren und deren Verwendungen
|
WO2004061423A2
(en)
|
2003-01-06 |
2004-07-22 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
ES2712695T3
(es)
|
2003-06-02 |
2019-05-14 |
Univ Massachusetts |
Métodos y composiciones para controlar la eficacia de la silenciación del ARN
|
AU2004252442B2
(en)
|
2003-06-02 |
2010-04-08 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of FNAi
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US7888121B2
(en)
*
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
WO2005017119A2
(en)
|
2003-08-14 |
2005-02-24 |
Exelixis, Inc. |
Ups as modifiers of the beta catenin pathway and methods of use
|
CA2761987A1
(en)
|
2003-10-07 |
2005-04-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
WO2005046450A2
(en)
|
2003-11-12 |
2005-05-26 |
Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
EP2186913B1
(de)
|
2003-11-26 |
2016-02-10 |
Celera Corporation |
Mit kardiovaskulären Erkrankungen und dem Ansprechen auf Medikation in Zusammenhang stehende Genpolymorphismen, Methoden zu deren Nachweis und deren Verwendung
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
CN101014715A
(zh)
|
2004-04-22 |
2007-08-08 |
麒麟麦酒株式会社 |
转基因动物及其用途
|
JP5236286B2
(ja)
|
2004-05-07 |
2013-07-17 |
セレラ コーポレーション |
肝線維症に関連する遺伝的多型、その検出方法および使用
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
CA2584331A1
(en)
|
2004-10-22 |
2006-05-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating pgc-1.beta. to treat lipid-related diseases and disorders
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
WO2006099365A2
(en)
|
2005-03-11 |
2006-09-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
US20070056050A1
(en)
*
|
2005-06-29 |
2007-03-08 |
Clokie Cameron M L |
PRODUCTION OF BONE MORPHOGENIC PROTEINS (BMPs) IN TRANSGENIC MAMMALS
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
CA2617930A1
(en)
|
2005-08-09 |
2007-03-29 |
Revivicor, Inc. |
Transgenic ungulates expressing ctla4-ig and uses thereof
|
AU2006287315B2
(en)
|
2005-09-09 |
2013-02-21 |
The Johns Hopkins University |
Manipulation of regulatory T cell and DC function by targeting neuritin gene using antibodies, agonists and antagonists
|
US8921109B2
(en)
|
2005-09-19 |
2014-12-30 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
US8173860B2
(en)
|
2006-04-21 |
2012-05-08 |
Gtc Biotherapeutics, Inc. |
Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
|
ES2378407T3
(es)
|
2006-09-01 |
2012-04-12 |
Therapeutic Human Polyclonals, Inc. |
Aumento de la expresión de inmunoglobulina humana o humanizada en animales transgénicos no humanos
|
EP2064345B1
(de)
|
2006-09-11 |
2013-03-13 |
Celera Corporation |
Psoriasis-assoziierte genetische polymorphismen, nachweisverfahren dafür und ihre verwendung
|
CA2915679C
(en)
|
2006-10-20 |
2017-12-12 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
KR101398220B1
(ko)
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
US20100205678A1
(en)
*
|
2007-01-05 |
2010-08-12 |
Overstrom Eric W |
Oocyte spindle-associated factors improve somatic cell cloning
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
EP2214708A4
(de)
|
2007-10-26 |
2011-01-12 |
Centocor Ortho Biotech Inc |
Vektoren, wirtszellen und herstellungsverfahren und verwendungen
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
EP2232985A4
(de)
|
2008-01-04 |
2011-02-16 |
Seoul Nat Univ Ind Foundation |
Verfahren zur herstellung geklonter transgener canidae
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
WO2009114185A2
(en)
|
2008-03-12 |
2009-09-17 |
The Rockefeller University |
Methods and compositions for translational profiling and molecular phenotyping
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
WO2009134130A2
(en)
|
2008-05-02 |
2009-11-05 |
Pharming Intellectual Property Bv |
Treatment of bleeding with low half-life fibrinogen
|
JP5688970B2
(ja)
|
2008-07-07 |
2015-03-25 |
タカラバイオ株式会社 |
多能性幹細胞の製造方法
|
EP2733222A1
(de)
|
2008-07-09 |
2014-05-21 |
Celera Corporation |
Mit kardiovaskulären Krankheiten assoziierte, genetische Polymorphismen, Verfahren zum Nachweis und Verwendungen davon
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
WO2010124200A2
(en)
|
2009-04-23 |
2010-10-28 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cancer
|
EP2267153A1
(de)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identifizierung der Netrin-1-Rezeptor-unc5c-Genmutation bei festen Krebsen
|
US9314005B2
(en)
|
2009-07-01 |
2016-04-19 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (SCID)
|
WO2011011678A2
(en)
|
2009-07-24 |
2011-01-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
US20110035816A1
(en)
|
2009-08-05 |
2011-02-10 |
Ostertag Eric M |
Genetically Modified Rat Models for Drug Metabolism
|
WO2011022634A2
(en)
|
2009-08-20 |
2011-02-24 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pain
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
WO2011091134A2
(en)
|
2010-01-22 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
AU2011230537C1
(en)
|
2010-03-26 |
2018-08-02 |
Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
US8956865B2
(en)
|
2010-08-11 |
2015-02-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods of growing an embryo to a blastocyst stage of development
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
WO2012071393A2
(en)
|
2010-11-23 |
2012-05-31 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
ES2680636T3
(es)
|
2011-02-14 |
2018-09-10 |
Revivicor Inc. |
Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
MX357421B
(es)
|
2011-05-16 |
2018-07-09 |
Univ Missouri |
Animales resistentes al virus del sindrome reproductivo y respiratorio porcino.
|
WO2013039996A1
(en)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
SI2814844T1
(sl)
|
2012-02-15 |
2017-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo in blokirajo sprožilni receptor, izražen na mieloidnih celicah-1 (trem-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP3421486B1
(de)
|
2012-06-22 |
2023-09-27 |
The Trustees Of Dartmouth College |
Neuartige vista-ig-konstrukte und verwendung von vista-ig zur behandlung von autoimmun-, allergischen und entzündungserkrankungen
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CN109793893B
(zh)
|
2012-09-07 |
2023-05-26 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
WO2014140927A2
(en)
|
2013-02-13 |
2014-09-18 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
CA2900909A1
(en)
|
2013-02-13 |
2014-08-21 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof
|
PL2993234T3
(pl)
|
2013-04-30 |
2019-04-30 |
Univ Konkuk Ind Coop Corp |
Wektor ukierunkowany na hydroksylazę kwasu cmp-acetyloneuraminowego, zwierzę transgeniczne do ksenoprzeszczepu z wprowadzonym wektorem i sposób ich wytwarzania
|
EP4043493A1
(de)
|
2013-12-24 |
2022-08-17 |
Janssen Pharmaceutica NV |
Anti-vista-antikörper und -fragmente
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA2951885C
(en)
|
2014-06-11 |
2023-07-04 |
Kathy A. Green |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
FI3172232T3
(fi)
|
2014-07-17 |
2024-03-19 |
Novo Nordisk As |
TREM-1-vasta-aineiden kohdennettu mutageneesi viskositeetin alentamista varten
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
CN107405398A
(zh)
|
2014-12-05 |
2017-11-28 |
伊穆奈克斯特股份有限公司 |
鉴定vsig8作为推定vista受体及其用以产生vista/vsig8激动剂和拮抗剂的用途
|
SI3230320T1
(sl)
|
2014-12-09 |
2021-02-26 |
Regeneron Pharmaceuticals, Inc. |
Nehumane živali s humaniziranim genom označevalca pripadnosti 274
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
US10827730B2
(en)
|
2015-08-06 |
2020-11-10 |
The Curators Of The University Of Missouri |
Pathogen-resistant animals having modified CD163 genes
|
CA3002676A1
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
EP3413910A1
(de)
|
2016-02-12 |
2018-12-19 |
Janssen Pharmaceutica NV |
Anti-vista (b7h5)-antikörper
|
JP7277047B2
(ja)
|
2016-04-15 |
2023-05-18 |
イミュネクスト インコーポレイテッド |
抗ヒトvista抗体およびその使用
|
SG11202009625WA
(en)
|
2018-04-02 |
2020-10-29 |
Bristol Myers Squibb Co |
Anti-trem-1 antibodies and uses thereof
|
CN116536272A
(zh)
|
2018-04-06 |
2023-08-04 |
儿童医疗中心有限公司 |
用于体细胞重新编程和调整印记的组合物和方法
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
US20210188971A1
(en)
|
2019-12-19 |
2021-06-24 |
Quidel Corporation |
Monoclonal antibody fusions
|
AU2021385081A1
(en)
|
2020-11-20 |
2023-06-29 |
Revivicor, Inc. |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
CA3232376A1
(en)
|
2021-09-20 |
2023-03-23 |
Maria KOKKINAKI |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|